![]() ImCheck Therapeutics ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators . | |||
Founding Date | Founding Date 2013 | Founding Date 2015 | Founding Date 2016 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Smithfield, US | Locations Marseille, FR HQ | Locations Redwood City, US HQ Boston, US |
Employees | Employees 17423% increase | Employees 57 | Employees 1438% increase |
Valuation ($) | Valuation ($) 7.5 m | Valuation ($) N/A | Valuation ($) 116.2 m |
Financial | |||
Net income | Net income ($179.7m) (FY, 2022) | Net income N/A | Net income ($116.8m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 245m | Total funding raised $ 76.1m | Total funding raised $ 145.6m |

ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .
View company
Adicet Bio is a biotechnology company that develops therapies for cancer diseases.
View company